Triple Antibiotic
NDC 54473-291, Bacitracin zinc and Neomycin and Polymyxin B sulfate, ointment, from Melaleuca, Inc..
- Product NDC
- 54473-291
- Status
- Listed
- Labeler
- Melaleuca, Inc.
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M004
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/54473-291 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BACITRACIN ZINC500 U/g
- NEOMYCIN SULFATE3.5 mg/g
- POLYMYXIN B SULFATE10000 U/g
Pharmacologic classes
Aminoglycoside Antibacterial [EPC]; Aminoglycosides [CS]; Decreased Cell Wall Synthesis & Repair [PE]; Polymyxin-class Antibacterial [EPC]; Polymyxins [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 54473-291-01 | 54473029101 | 14 g in 1 TUBE (54473-291-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 54473-291 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/54473-291 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 54473-291. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.